Dataset Viewer: Search Results for "tmem106b protein"

Experiment #00000139

Foundational Dietary Theory: The dietary synergy between Hi-Maize and 6x Spermidine Yeast creates a potential cellular supply-and-clearance loop within the brain's astrocytes. Circulating spermidine metabolites utilize documented astrocytic polyamine uptake systems to access the central nervous system. Once inside, this exogenous spermidine drives FAM134B-mediated ER-phagy, clearing the endoplasmic reticulum matrix. This clearance removes the ER-stress bottleneck, allowing newly transcribed astrocytic EAAT2—upregulated by gut-derived butyrate from Hi-Maize fermentation—to successfully traffic to the plasma membrane and mitigate synaptic glutamate excitotoxicity.

Starch, Resistant _gates_from_starch__resistant Butyric Acid _gates_to_butyric_acid _gates_from_butyric_acid Glutamate Plasma Membrane Transport Proteins _gates_to_glutamate_plasma_membrane_transport_proteins Spermidine _gates_from_spermidine Autophagy

View Results

Experiment #00000138

Dietary butyrate from resistant starch may synergize with sulforaphane-driven Nrf2 activation and spermidine-mediated FAM134B ER-phagy in order to restore astrocytic EAAT2 membrane trafficking and potentially clear synaptic glutamate excitotoxicity in neurodegeneration. (Literature Based Discovery)

Starch, Resistant _gates_from_starch__resistant Butyrate _gates_to_butyrate _gates_from_butyrate NF-E2-Related Factor 2 _gates_to_nf_e2_related_factor_2 Sulforaphane _gates_from_sulforaphane Spermidine

View Results

Experiment #00000133

ApoE-mediated lipsignaling and EV-delivered bioenergetic substrates both converge on the stabilization of mitochondrial respiratory complexes, which is the requisite physiological precursor for renewed neurogenesis in the hippocampus.

Apolipoprotein E4 _gates_from_apolipoprotein_e4 Mitochondrial Respiration _gates_to_mitochondrial_respiration Extracellular Vesicles _gates_from_extracellular_vesicles Mitochondria _gates_to_mitochondria Energy Metabolism _gates_from_energy_metabolism

View Results

Experiment #00000132

Discovery: Considering PubMed #41177462, intranasal S-GEVs co-functionalized with ApoE peptides may bypass the cribriform plate and target astrocytic LRP1 receptors in order to suppress NF-κB and may resolve some neuroinflammation in Alzheimer's and ALS.

Administration, Intranasal _gates_from_administration__intranasal Blood-Brain Barrier _gates_to_blood_brain_barrier Apolipoproteins E _gates_from_apolipoproteins_e Low Density Lipoprotein Receptor-Related Protein-1 _gates_to_low_density_lipoprotein_receptor_related_protein_1 Signal Transduction _gates_from_signal_transduction

View Results

Experiment #00000128

Discovered Hypothesis: Spermidine-mediated autophagic activation may serve as an upstream regulator of lysosomal TMEM175 activity to prevent proteinopathy in C9orf72-ALS/FTD models.

Spermidine _gates_from_spermidine Autophagy _gates_to_autophagy _gates_from_autophagy Lysosomal Integrity _gates_to_lysosomal_integrity _gates_from_lysosomal_integrity TMEM175 _gates_to_tmem175

View Results

Experiment #00000127

Neuroinflammatory astrocyte subtypes in the mouse brain

Pathologic Processes _gates_from_pathologic_processes Gene Expression Regulation _gates_to_gene_expression_regulation _gates_from_gene_expression_regulation Biological Phenomena _gates_to_biological_phenomena _gates_from_biological_phenomena Neuroinflammatory Diseases _gates_to_neuroinflammatory_diseases

View Results

Experiment #00000126

Hypothesis: Intranasal delivery of Spermidine-modified Ginseng Extracellular Vesicles (S-GEVs) loaded with multi-targeted mRNA suppresses MARK2-eIF2α-driven RAN translation to prevent dipeptide repeat clogging of FG-nucleoporins, synergizing with progranulin-mediated lysosomal clearance to arrest TMEM106B amyloid accumulation and block the execution of p38-Lamin B1-dependent Karyoptosis in motor neurons.

Spermidine _gates_from_spermidine Lysosomal Degradation _gates_to_lysosomal_degradation _gates_from_lysosomal_degradation Protein Aggregates _gates_to_protein_aggregates _gates_from_protein_aggregates Cell Death _gates_to_cell_death

View Results

Experiment #00000125

Discovery: Considering PubMed #37563705, #42012729, and #42541426, Spermidine is a known inducer of autophagy through EP300 inhibition and TFEB activation. Since TMEM106B amylofilaments induce lysosomal dysfunction, TFEB-driven restoration of lysosomal capacity would logically prevent the accumulation of these filaments.

Spermidine _gates_from_spermidine Transcription Factor EB _gates_to_transcription_factor_eb _gates_from_transcription_factor_eb Lysosomes _gates_to_lysosomes _gates_from_lysosomes TMEM106B protein _gates_to_tmem106b_protein

View Results

Experiment #00000124

Hypothesis: Intranasal delivery of Spermidine-modified Ginseng Extracellular Vesicles (S-GEVs) loaded with GRN mRNA exploits the cribriform plate anatomy to bypass the blood-brain barrier, providing a neuro-targeted delivery system for progranulin gene therapy that acts synergistically with spermidine-induced autophagy to suppress pathological TMEM106B amyloid accumulation and restore endolysosomal homeostasis.

Administration, Intranasal _gates_from_administration__intranasal Olfactory Bulb _gates_to_olfactory_bulb Progranulins _gates_from_progranulins _gates_to_progranulins RNA, Messenger _gates_from_rna__messenger PGRN protein

View Results

Experiment #00000123

Hypothesis: Intranasal delivery of Spermidine-modified Ginseng Extracellular Vesicles (S-GEVs) loaded with GRN mRNA exploits the cribriform plate anatomy to bypass the blood-brain barrier, providing a neuro-targeted delivery system for progranulin gene therapy that acts synergistically with spermidine-induced autophagy to suppress pathological TMEM106B amyloid accumulation and restore endolysosomal homeostasis.

Administration, Intranasal _gates_from_administration__intranasal Olfactory Bulb _gates_to_olfactory_bulb Progranulins _gates_from_progranulins _gates_to_progranulins RNA, Messenger _gates_from_rna__messenger PGRN protein

View Results

Experiment #00000120

Discovery: Considering PubMed #41177462 and PubMed #41231952, Spermidine-modified extracellular vesicles can mitigate ALS-related C9orf72 RAN translation by modulating the MARK2-eIF2α stress-sensing axis.

C9orf72 Protein _gates_from_c9orf72_protein EIF2A _gates_to_eif2a _gates_from_eif2a Nanoparticles _gates_to_nanoparticles

View Results

Experiment #00000119

Hypothesis: Considering PubMed #41177462, Intranasally administered GDEVs, specifically spermidine-modified ginger extracellular vesicles, may offer a multi-target therapeutic strategy for C9orf72-associated ALS by crossing the blood-brain barrier via olfactory routes to potentially deliver gene-editing components, support axonal translation, restore STMN2 expression, and attenuate neuroinflammation.

Spermidine _gates_from_spermidine Olfactory Bulb _gates_to_olfactory_bulb Drug Delivery Systems _gates_from_drug_delivery_systems Stathmin 2 _gates_to_stathmin_2 Eukaryotic Initiation Factor-5A _gates_from_eukaryotic_initiation_factor_5a

View Results

Experiment #00000116

How do electrophilic binding and charge polarity modulate proteinopathy in Alzheimer's Disease, specifically regarding BBB interactions?

Metabolic State _gates_from_metabolic_state βHB Production _gates_to___hb_production 3-Hydroxybutyric Acid _gates_from_3_hydroxybutyric_acid Protein Aggregates _gates_to_protein_aggregates _gates_from_protein_aggregates Autophagy

View Results

Experiment #00000115

Ebola Virus Outbreak Solution Hypothesis: Oral ginger-derived extracellular vesicles may serve as an acid-stable, inexpensive, and supply-chain ready clinical solution to deliver 6-shogaol to macrophages, triggering CASA autophagy to degrade EBOV VP40 and halt viral egress.

Ginger extract _gates_from_ginger_extract Autophagy _gates_to_autophagy Autophagy (CASA) _gates_from_autophagy__casa_ Viral Matrix Proteins _gates_to_viral_matrix_proteins Proteolysis _gates_from_proteolysis

View Results

Experiment #00000111

Identify specific patterns of TDP-43 proteinopathy induced cryptic mis-splicing of STMN2 and other "cryptic mis-splicing" patterns found within PubMed Literature, 2026.

DNA-Binding Protein 43 _gates_from_dna_binding_protein_43 Exons _gates_to_exons _gates_from_exons Protein Deficiency _gates_to_protein_deficiency Functional Protein Loss _gates_from_functional_protein_loss Neurodegeneration

View Results

Experiment #00000110

Karyoptosis mediates cell death and neurodegeneration upon proteotoxic stress.

Proteotoxic Stress _gates_from_proteotoxic_stress Cell Death _gates_to_cell_death _gates_from_cell_death Neurodegeneration _gates_to_neurodegeneration p38 Mitogen-Activated Protein Kinases _gates_to_p38_mitogen_activated_protein_kinases _gates_from_p38_mitogen_activated_protein_kinases

View Results

Experiment #00000108

Restoration of efferocytosis is highly dependent on macrophage polarization states; M1 and M2 phenotypes can both contribute to resolution if metabolic cues are corrected.

Metabolic Signaling _gates_from_metabolic_signaling Efferocytic Capacity _gates_to_efferocytic_capacity PIEZO1 Protein _gates_from_piezo1_protein Calcium Influx _gates_to_calcium_influx _gates_from_calcium_influx Metabolic/Efferocytic Pathways

View Results

Experiment #00000105

Gap Analysis: There is no PubMed data showing wet lab data or analysis of TPD-43 proteinopathy found (or not found) in the Cochlear, Spiral, or Scarpa's Ganglion of Amyotrophic Lateral Sclerosis patient data post mortem.

Amyotrophic Lateral Sclerosis _gates_from_amyotrophic_lateral_sclerosis TDP-43 proteinopathy _gates_to_tdp_43_proteinopathy _gates_from_tdp_43_proteinopathy Spiral Ganglion _gates_to_spiral_ganglion Peripheral Nerves _gates_from_peripheral_nerves _gates_to_amyotrophic_lateral_sclerosis

View Results

Experiment #00000101

Hypothesis: If Botox were injected into the nerve ending on the third toe on the left foot, the toxin can "climb" retrograde from toe through motor neurons eventually to the brain and temporarily inhibit vesicular docking "from toe to head", potentially allowing a timed pharmacological therapeutic window for toxic EV clearance through the lymph system instead of docking and seeding.

Botulinum Toxins, Type A _gates_from_botulinum_toxins__type_a Axonal Transport _gates_to_axonal_transport _gates_from_axonal_transport SNARE Proteins _gates_to_snare_proteins _gates_from_snare_proteins Lymphatic Vessel Endothelial Hyaluronan Receptor-1 _gates_to_lymphatic_vessel_endothelial_hyaluronan_receptor_1

View Results

Experiment #00000098

A 3x3 Evaluation Matrix of Biological Interactions of ARHGAP32, RGNEF (ARHGEF28), and TDP-43 in Neurodegenerative Disease found in PubMed Literature as of August 5, 2026

TDP-43 Proteinopathies _gates_from_tdp_43_proteinopathies RNA Splicing _gates_to_rna_splicing RGNEF (ARHGEF28) _gates_from_rgnef__arhgef28_ TDP-43 _gates_to_tdp_43

View Results

Experiment #00000097

Evaluation of Known Roles of ARHGAP32, RGNEF (ARHGEF28), and TDP-43 in Neurodegenerative Disease found in PubMed Literature as of August 5, 2026

DNA-Binding Proteins _gates_from_dna_binding_proteins RNA Splicing _gates_to_rna_splicing _gates_from_rna_splicing Neuronal Plasticity _gates_to_neuronal_plasticity Synaptic Transmission _gates_to_synaptic_transmission Neuronal Dysfunction

View Results

Experiment #00000096

analysis of the splicing landscape of the frontal cortex in ftld-tdp reveals subtype specific patterns and cryptic splicing

Frontotemporal Lobar Degeneration _gates_from_frontotemporal_lobar_degeneration Alternative Splicing _gates_to_alternative_splicing _gates_from_alternative_splicing RNA Splicing _gates_to_rna_splicing _gates_from_rna_splicing Subtype Specificity _gates_to_subtype_specificity

View Results

Experiment #00000090

Ferroptosis

Ferroptosis _gates_from_ferroptosis _gates_to_ferroptosis Spinal Cord Injuries _gates_from_spinal_cord_injuries Cell Death _gates_to_cell_death _gates_from_cell_death CD14 Antigen _gates_to_cd14_antigen

View Results

Experiment #00000089

Use of MBTPS1 inhibitors is a plausible strategy to prevent the terminal phase of nuclear death in specific cellular contexts.

Membrane-Bound Transcription Factor Peptidase, Site 1 _gates_from_membrane_bound_transcription_factor_peptidase__site_1 SREBP Activation _gates_to_srebp_activation _gates_from_srebp_activation Cellular Lipid Homeostasis _gates_to_cellular_lipid_homeostasis _gates_from_cellular_lipid_homeostasis Terminal Cell Death _gates_to_terminal_cell_death

View Results

Experiment #00000088

Stabilizing the CREB3 tether via S1P/S2P protease inhibition represents a novel mechanism to prevent the terminal phase of neuronal death.

Endoplasmic Reticulum Stress _gates_from_endoplasmic_reticulum_stress Proteolysis _gates_to_proteolysis _gates_from_proteolysis Cyclic AMP-Response Element-Binding Protein _gates_to_cyclic_amp_response_element_binding_protein _gates_from_cyclic_amp_response_element_binding_protein Nuclear Envelope _gates_to_nuclear_envelope

View Results

Experiment #00000087

Karyoptosis, Apoptosis, Ferroptosis: An Amyotrophic Lateral Sclerosis Study of PubMed Literature

Proteotoxic stress _gates_from_proteotoxic_stress Karyoptosis (LaminB1 path) _gates_to_karyoptosis__laminb1_path_ Cell Death _gates_from_cell_death Ferroptosis _gates_to_ferroptosis _gates_from_ferroptosis Lipid Metabolism

View Results

Experiment #00000086

Parkinson's Disease versus Alzheimer's Disease: Shared and Exclusive Pathways

Pathologic Processes _gates_from_pathologic_processes Mitochondrial Diseases _gates_to_mitochondrial_diseases Lipid Metabolism Disorders _gates_from_lipid_metabolism_disorders Lipid Droplet Accumulation _gates_to_lipid_droplet_accumulation _gates_from_lipid_droplet_accumulation Lysosomal Storage Diseases

View Results

Experiment #00000085

apo-SOD1 research, July 2026

Superoxide Dismutase-1 _gates_from_superoxide_dismutase_1 Oligomerization _gates_to_oligomerization _gates_from_oligomerization Prions _gates_to_prions Protein Folding _gates_to_protein_folding _gates_from_protein_folding

View Results

Experiment #00000084

SOD1 Research July 2026

Genetic Testing _gates_from_genetic_testing Drug Delivery Systems _gates_to_drug_delivery_systems _gates_from_drug_delivery_systems Superoxide Dismutase-1 _gates_to_superoxide_dismutase_1 Protein Aggregates _gates_from_protein_aggregates Oxidative Stress

View Results

Experiment #00000076

Nanoplastic-induced lysosomal membrane remodeling may sequester WDR44, creating a 'hotspot' for α-synuclein aggregation initiation.

Nanoplastics internalization _gates_from_nanoplastics_internalization Lysosomal accumulation _gates_to_lysosomal_accumulation _gates_from_lysosomal_accumulation Lysosomal Membranes _gates_to_lysosomal_membranes WDR44 _gates_from_wdr44 WDR44 protein

View Results

Experiment #00000075

Polystyrene nanoplastics (PS-NPs) may act as a scaffold for the recruitment and accumulation of WDR44 at the lysosomal membrane, thereby accelerating the de novo aggregation of alpha-synuclein in the early stages of PD.

Nanoplastic exposure _gates_from_nanoplastic_exposure Lysosomal Storage Diseases _gates_to_lysosomal_storage_diseases _gates_from_lysosomal_storage_diseases alpha-Synuclein _gates_to_alpha_synuclein WDR44 _gates_from_wdr44 Protein Aggregates

View Results

Experiment #00000074

OGT (O-GlcNAc transferase) modulation via pharmacological agonists can prevent degeneration of cranial nerves following traumatic or surgical stress.

Trauma/Stress _gates_from_trauma_stress Ferritinophagy/Oxidative Stress _gates_to_ferritinophagy_oxidative_stress Autophagy _gates_from_autophagy N-Acetylglucosaminyltransferases _gates_to_n_acetylglucosaminyltransferases _gates_from_n_acetylglucosaminyltransferases Neuronal Survival

View Results

Experiment #00000070

What types of infections might cause a high C-Reactive Protein result?

Pathogen presence _gates_from_pathogen_presence Immunity, Innate _gates_to_immunity__innate _gates_from_immunity__innate C-Reactive Protein _gates_to_c_reactive_protein _gates_from_c_reactive_protein Biomarkers _gates_to_biomarkers

View Results

Experiment #00000068

ALS; FUS; STMN2; TDP-43; protein translation; stress granule

Cell Nucleus _gates_from_cell_nucleus RNA Splicing _gates_to_rna_splicing _gates_from_rna_splicing Protein Biosynthesis _gates_to_protein_biosynthesis _gates_from_protein_biosynthesis Motor Neuron Disease _gates_to_motor_neuron_disease

View Results

Experiment #00000067

Frontotemporal dementia; Splicing; TDP-43; Transcriptomics.

DNA-Binding Protein-43 _gates_from_dna_binding_protein_43 RNA Splicing _gates_to_rna_splicing _gates_from_rna_splicing Neuronal dysfunction _gates_to_neuronal_dysfunction Exons _gates_to_exons Splicing defects

View Results

Experiment #00000065

Does pathologically seeded TDP-43 exit the retina via anterograde axonal transport along the optic tract to midbrain hubs, enter the systemic circulation inside extracellular vesicles, and subsequently traffic into pancreatic beta-cells to accelerate type 2 diabetes phenotypes?

TAR DNA-Binding Protein 43 _gates_from_tar_dna_binding_protein_43 Extracellular Vesicles _gates_to_extracellular_vesicles Systemic circulating EVs _gates_from_systemic_circulating_evs Insulin-Secreting Cells _gates_to_insulin_secreting_cells Axonal Transport _gates_to_axonal_transport

View Results

Experiment #00000064

Lon Protease, Alternaria; IL-33; TSLP; alarmins; asthma; chronic rhinosinusitis; fungal allergen; innate lymphoid cells

Alternaria _gates_from_alternaria Alarmins _gates_to_alarmins _gates_from_alarmins Immunity, Innate _gates_to_immunity__innate _gates_from_immunity__innate Lon-Peptidase _gates_to_lon_peptidase

View Results

Experiment #00000056

Sarcopenia and Amyotrophic Lateral Sclerosis: Biological Pathways and Analysis

Motor Neuron Disease _gates_from_motor_neuron_disease Neuromuscular Junction Diseases _gates_to_neuromuscular_junction_diseases _gates_from_neuromuscular_junction_diseases Muscle Weakness _gates_to_muscle_weakness NMJ instability _gates_from_nmj_instability Sarcopenia

View Results

Experiment #00000055

If the RGNEF NF 242 Terminal loses its functional ability to agitate or compete with TDP-43, perhaps from misfolding or sequestration, could it cause the TDP-43 proteinopathy seen in the retina, post-mortem, in Sporadic Amyotrophic Lateral Sclerosis patients, if the RGNEF failures were localized in the retina?

RGNEF/NF242 _gates_from_rgnef_nf242 TDP-43 _gates_to_tdp_43 Rho Guanine Nucleotide Exchange Factor _gates_from_rho_guanine_nucleotide_exchange_factor TDP-43 Proteinopathies _gates_to_tdp_43_proteinopathies Amyotrophic Lateral Sclerosis _gates_from_amyotrophic_lateral_sclerosis

View Results

Experiment #00000054

What dietary habits are beneficial towards reducing excess/harmful tyramine in order to improve liver and gut health?

Dietary Proteins _gates_from_dietary_proteins Aromatic-L-Amino-Acid Decarboxylases _gates_to_aromatic_l_amino_acid_decarboxylases _gates_from_aromatic_l_amino_acid_decarboxylases Tyramine _gates_to_tyramine _gates_from_tyramine Gastrointestinal Diseases _gates_to_gastrointestinal_diseases

View Results

Experiment #00000051

Is TDP-43 proteinopathy associated with toxoplasmosis?

Datasets as Topic _gates_from_datasets_as_topic Toxoplasmosis or Toxoplasma gondii _gates_to_toxoplasmosis_or_toxoplasma_gondii TAR DNA-Binding Protein 43 _gates_from_tar_dna_binding_protein_43 _gates_to_datasets_as_topic Toxoplasmosis _gates_from_toxoplasmosis Not Found

View Results

Experiment #00000048

The ALS-T2D comorbidity is driven by a bidirectional, exosome-mediated proteostatic collapse. Peripheral tissues (muscle, pancreas) dictate CNS TDP-43 stability via exosomal miRNAs (miR-126a-5p) and glucose-dependent modifications (O-GlcNAcylation). Conversely, pharmacological activation of ubiquitin-peptidases (e.g., Acarbose targeting USP46) or restitution of glycolytic cofactors (F2,6BP) represent novel, cross-disciplinary therapeutic targets capable of halting systemic proteinopathy.

Diabetes Mellitus, Type 2 _gates_from_diabetes_mellitus__type_2 Extracellular Vesicles _gates_to_extracellular_vesicles _gates_from_extracellular_vesicles DNA-Binding Proteins _gates_to_dna_binding_proteins _gates_from_dna_binding_proteins Amyotrophic Lateral Sclerosis _gates_to_amyotrophic_lateral_sclerosis

View Results

Experiment #00000047

Does blast-induced mild traumatic brain injury (mTBI) drive progressive tau/TDP-43 seeding by disrupting astrocytic AQP4 glymphatic clearance and activating microglial cGAS-STING neuroinflammation? #mTBI #Glymphatic #cGASSTING

Blast Injuries _gates_from_blast_injuries Aquaporin 4 _gates_to_aquaporin_4 _gates_from_aquaporin_4 Glymphatic System _gates_to_glymphatic_system _gates_from_glymphatic_system Protein Aggregates _gates_to_protein_aggregates

View Results

Experiment #00000042

#PITRM1 #ALS #Microglia #Mitochondria

PITRM1 protein, human _gates_from_pitrm1_protein__human Unfolded Protein Response _gates_to_unfolded_protein_response Mitochondrial Stress _gates_from_mitochondrial_stress DNA, Mitochondrial _gates_to_dna__mitochondrial _gates_from_dna__mitochondrial Neuroinflammation

View Results

Experiment #00000039

What is the current evidence for RGNEF (ARHGEF28) functioning as a primary upstream regulator of axonal transport and TDP-43 homeostasis in ALS, and how does the failure of this 'terminal tether' initiate the pathological continuum compared to downstream protein aggregation?

Metabolic Stress _gates_from_metabolic_stress Protein Aggregation _gates_to_protein_aggregation _gates_from_protein_aggregation RNA Metabolism _gates_to_rna_metabolism _gates_from_rna_metabolism Axonal Transport _gates_to_axonal_transport

View Results

Experiment #00000038

Map the direct mechanical and axonal transport pathways connecting intranasal administration or trigeminal nerve delivery to the clearance of TDP-43 aggregates in sporadic ALS, and the delivery of CRISPR-Cas/ASO gene therapies targeting C9orf72 hexanucleotide repeat expansions in the cerebellum and brainstem.

Intranasal Route _gates_from_intranasal_route Blood-Brain Barrier _gates_to_blood_brain_barrier C9orf72 Protein _gates_to_c9orf72_protein _gates_from_c9orf72_protein Brain _gates_to_brain Intranasal Administration

View Results

Experiment #00000037

How does karyoptosis occur compared to apoptosis? SOD1 seems to be associated with apoptosis in some ALS phenotypes, but is SOD1 associated with ALS pathological karyoptosis as well?

Proteotoxic stress _gates_from_proteotoxic_stress p38 kinase signaling _gates_to_p38_kinase_signaling _gates_from_p38_kinase_signaling Apoptosis _gates_to_apoptosis Superoxide Dismutase-1 _gates_from_superoxide_dismutase_1 Karyoptosis (LaminB1 phosphorylation)

View Results

Experiment #00000036

What is Karyoptosis and how does it align with past and present neurodegenerative disease research? Does Karyoptosis provide a new context in which a new class of repurposed therapeutics is formed?

Proteotoxic Stress _gates_from_proteotoxic_stress Cyclic AMP-Response Element Binding Protein _gates_to_cyclic_amp_response_element_binding_protein _gates_from_cyclic_amp_response_element_binding_protein Nuclear Envelope _gates_to_nuclear_envelope _gates_from_nuclear_envelope Apoptosis _gates_to_apoptosis

View Results

Experiment #00000031

Why are frontotemporal dementia and c9orf72 ALS considered different diseases if they are both driven by the same abnormal expansion of a GGGGCC (G₄C₂) sequence in the first intron of the C9orf72 gene? Is it logical to think that CRISPR therapeutics for FTD potentially be used for ALS as well?

C9orf72 expansion _gates_from_c9orf72_expansion Gene Expression Regulation _gates_to_gene_expression_regulation _gates_from_gene_expression_regulation Protein Aggregation, Pathological _gates_to_protein_aggregation__pathological _gates_from_protein_aggregation__pathological CRISPR-Cas Systems _gates_to_crispr_cas_systems

View Results

Experiment #00000030

Can AI and single-cell RNA sequencing help map cryptic TDP-43 splicing errors in sporadic ALS to design BBB-penetrant CRISPR gene therapies before neurotoxicity begins?

Single-Cell Analysis _gates_from_single_cell_analysis RNA Splicing _gates_to_rna_splicing _gates_from_rna_splicing Blood-Brain Barrier _gates_to_blood_brain_barrier _gates_from_blood_brain_barrier Neurotoxicity Syndromes _gates_to_neurotoxicity_syndromes

View Results

Experiment #00000024

If RGNEF fails agitate and regulate TDP-43 at the RGNEF NF242 Terminal, does this cause TDP-43 propteinopathy?

Protein Interaction Mapping _gates_from_protein_interaction_mapping RNA Stability _gates_to_rna_stability Peptide Fragments _gates_from_peptide_fragments RNA Recognition Motif _gates_to_rna_recognition_motif Metabolic stress _gates_from_metabolic_stress

View Results

Experiment #00000023

Does misfolded TDP43 affect Retinal Ganglion Cell STMN2 ability to repair in a similar way as what how it was shown to affect motor neurons with cryptic mis-splicing?

TDP-43 pathology _gates_from_tdp_43_pathology RNA Splicing _gates_to_rna_splicing _gates_from_rna_splicing Stathmin 2 _gates_to_stathmin_2 Vitreous Body _gates_to_vitreous_body DNA-Binding Protein-43

View Results

Experiment #00000022

Do Bulbar Amyotrophic Lateral Sclerosis patients have TDP43 proteinopathy in cochlear/spiral ganglion post mortem?

Ubiquilin-1 _gates_from_ubiquilin_1 TDP-43 Proteinopathies _gates_to_tdp_43_proteinopathies _gates_from_tdp_43_proteinopathies Amyotrophic Lateral Sclerosis _gates_to_amyotrophic_lateral_sclerosis Disease Models, Animal _gates_from_disease_models__animal Cochlear Nucleus

View Results

Experiment #00000016

Analyze the potential for zinc-binding competition between synaptic transporters (e.g., SLC39A8, ZnT3) and ALS-associated proteins (RGNEF, TDP-43) in the RGC-thalamic axis. Can this competition explain the coexistence of RGC excitotoxicity and STMN2 depletion in clinical samples?

TAR DNA-Binding Protein 43 _gates_from_tar_dna_binding_protein_43 Stathmin 2 _gates_to_stathmin_2 SLC39A8 protein, human _gates_from_slc39a8_protein__human Zinc _gates_to_zinc Excitotoxicity _gates_from_excitotoxicity

View Results

Experiment #00000015

Given that schizophrenia is characterized by a deficit in the attenuation of sensory input via corollary discharge, how might pathologically elevated RGC signaling—potentially caused by synaptic glutamate overflow without zinc modulation—interfere with the thalamic integration of extra-retinal CD signals to effectively reverse the predictive timing of visual stability?

SLC39A8 Protein _gates_from_slc39a8_protein Zinc Deficiency _gates_to_zinc_deficiency _gates_from_zinc_deficiency Glutamic Acid _gates_to_glutamic_acid _gates_from_glutamic_acid Thalamus _gates_to_thalamus

View Results

Experiment #00000012

If a toxin with a thermodynamic affinity for Zinc GREATER THAN that of Glutamate AND LESS THAN that of RGNEF, under certain conditions a pathway exists wherein the toxin could shuttle synaptic retinal zinc to RGNEF, thus potentially ultimately resulting in the retinal TDP-43 proteinopathy seen in the retina post mortem in Sporadic Amyotrophic Lateral Sclerosis

Synaptic Zinc _gates_from_synaptic_zinc Receptors, Glutamate _gates_to_receptors__glutamate _gates_from_receptors__glutamate Zinc Dyshomeostasis in RGCs _gates_to_zinc_dyshomeostasis_in_rgcs _gates_from_zinc_dyshomeostasis_in_rgcs TDP-43 Proteinopathy _gates_to_tdp_43_proteinopathy

View Results

Experiment #00000007

Simply put, we still don’t know why neurons are dying in ALS, and why motor neurons die while other types of neurons don’t. Even for genetic forms c9orf72 familial ALS, why is it that the mutation is in every cell but the motor neurons are dying ie have increased susceptibility?

Axonal Transport _gates_from_axonal_transport Motor Neuron Disease _gates_to_motor_neuron_disease C9orf72 Repeat Expansion _gates_from_c9orf72_repeat_expansion Dipeptide Repeats _gates_to_dipeptide_repeats _gates_from_dipeptide_repeats VAPB protein, human

View Results

Experiment #00000006

Does existing in vitro data show that Quercetin-induced autophagy can successfully degrade DUX4 or its downstream misfolded proteins?

Quercetin _gates_from_quercetin Autophagy _gates_to_autophagy _gates_from_autophagy Misfolded Proteins _gates_to_misfolded_proteins _gates_from_misfolded_proteins DUX4 _gates_to_dux4

View Results

Experiment #00000005

What are the biomarker differences in TDP-43 proteinopathy within the cerebellum and retina when comparing Sporadic Amyotrophic Lateral Sclerosis and c9orf72 affected Familial Amyotrophic Lateral Sclerosis? Are there any mutually exclusive biomarkers that can be deduced?

C9orf72 expansion _gates_from_c9orf72_expansion Dipeptide Repeats _gates_to_dipeptide_repeats _gates_from_dipeptide_repeats Microglia _gates_to_microglia C9orf72 Protein _gates_from_c9orf72_protein Cerebellum

View Results

PathMap Literature Based Discovery Engine

Guaranteed to find unpublished literature based discoveries.